Tenax Therapeutics Reports Fiscal Year 2021 Results and Provides Business Update

Author's Avatar
Mar 31, 2022

Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, today reported financial results for the year ended December 31, 2021 and provided a business update.